Skip to content
Medical Health Aged Care

Snapshot of palliative care in Australia

Palliative Care Australia 2 mins read

New data from the Australian Institute of Health and Welfare (AIHW) gives an insight into palliative care in Australia.

“This AIHW data gives us a snapshot of how palliative care is delivered and is an important piece of the puzzle as government progresses reforms in primary health and aged care, which PCA hopes will improve access to palliative care,” says Camilla Rowland, Chief Executive Officer, Palliative Care Australia (PCA).

Among some of the findings of the ‘Palliative care services in Australia’ report, is that hospitalisations continue to increase.

“We are consistently seeing the number of palliative care-related hospitalisations increasing at a faster rate than for all hospitalisations – a 29% increase compared with a 10% overall increase over the seven years up to 2021-22,” Ms Rowland says.

“And the average length of stay is almost twice as long – 10.3 days for palliative care compared with 5.7 days for all hospitalisations.

“Increasing hospitalisations have a huge impact on the workings of our health system and perhaps means that people aren’t getting the choice they deserve at the end of their life.”

Beyond hospital care, as the AIHW acknowledges, general practitioners and the primary health sector can play an integral part in the delivery of palliative care.

Ms Rowland adds, “the 2022-23 Federal Budget introduced a new Medicare item for GPs to claim against, known as Level E, GPs now have the ability to charge for longer appointments, which we believe will benefit those seeking palliative care and allow people to stay at home.”

“The palliative care sector is working hard to upskill GPs and other primary health providers in palliative care. There are a range of education and training tools available to help meet the growing demand.”

Palliative care training and education for primary health:

“For most people with a life limiting illness, whether they are living at home or in an aged care facility - local GP’s, nurses, and allied health professionals can deliver the palliative care needed - outside of the hospital and specialist palliative care system, but many don’t have the training to do so, that needs to change,” Ms Rowland says.

“With our ageing population and growing burden of chronic disease, Australia is on track for a 50% increase in demand for palliative care and a doubling in need by 2050. (KPMG)

“Death and the dying process touches us all whether we are the one with a life-limiting illness, a carer, or a loved one dealing with grief – more and more Australian families need the support of  palliative care.”

The full report from AIHW can be viewed HERE. 


Contact details:

Ian Campbell

P: 0417 482 171

E: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 12/04/2026
  • 07:10
Energy Enhancement System

Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered

Clark County judge finds defendant’s public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor…

  • Contains:
  • Medical Health Aged Care
  • 12/04/2026
  • 06:25
Royal Australian College of GPs

Cleanbill report shows bulk billing rises where funding is strongest, not where competition is greatest

The Royal Australian College of General Practitioners (RACGP) says new Cleanbill data indicates what GPs have consistently warned is true: bulk billing increases where funding better reflects the true cost of care, not where there is greater competition between practices. The Cleanbill report, released today, breaks down bulk billing and gap fees by how rural a practice is based on Modified Monash Model (MM1–7) classification. It shows that the largest increases in 100% bulk billing have occurred in regional and rural areas where government incentives are highest, yet where health department data show there are fewer GPs per person. RACGP…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.